ORPHELIA Pharma is delighted to invite you to attend its symposium on the use of temozolomide in the management of pediatric tumors and the development of Kimozo, the first ready-to-use, taste-masked oral suspension of temozolomide suitable for children. The symposium entitled “Improving children care with temozolomide oral suspension” will be held during the next SIOP annual congress which will take place from October 14th to 17th, 2020 in a fully virtual format.
During this session, two internationally renowned clinicians, Dr Lucas Moreno (Vall d’Hebron Hospital in Barcelona) and Dr Dominique Valteau-Couanet (Gustave Roussy in Villejuif) will highlight the role of temozolomide in the treatment of relapsed or refractory pediatric tumors and more particularly in neuroblastomas. Their speech will be followed by Dr Caroline Lemarchand, Director of Pharmaceutical Development of our laboratory, who will present Kimozo, the first pediatric formulation of temozolomide under clinical development developed by ORPHELIA Pharma.
This symposium will take place on Friday, October 16, 2020 from 9:15 a.m. to 9:35 a.m. (local Ottawa time), from 3:15 p.m. to 3:35 p.m. Central European Time (CET). To attend, you must connect to the SIOP website (SIOP-Congress.org), enter your username and password given when you registered for the congress, click on “Product Theater” and choose the virtual symposium of ORPHELIA Pharma.
Hoping to have you with us on this occasion, I already wish you an excellent SIOP 2020 congress.